German tax cuts welcomed by industry:
This article was originally published in Clinica
Executive Summary
Germany's medical device industry has welcomed the tax reform measures agreed by the upper and lower houses of parliament, the Bundesrat and Bundestag, which will result in the biggest tax cuts in the country's history. The tax relief legislation is due to come into effect on January 1 2001, with the DM60 billion ($29 billion) tax cuts being introduced in stages up to 2005. Joachim Schmitt, director general of BVMed, the German device industry association, said the tax reform programme was "extremely good news not only for medical device companies in Germany, but also for international manufacturers investing in Germany".
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.